2024 Annual Meeting | C38 - The Dystonias: Diagnosis, Treatment, and Update on Etiologies

Date Sunday 04/14/24

Time 07:00 AM - 09:00 AM MDT Add To Calendar

Location Colorado Convention Center | Four Seasons 4

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Ian Bledsoe, MD

Topic(s) Movement Disorders

Learning Objectives Participants should gain familiarity with the clinical features and phenomenology of dystonia; dystonia classification and differential diagnosis; the most common genetic forms of dystonia, recent genetic etiologies, and basis for clinical genetic testing in dystonia; and principles of treatment of dystonia with oral medications, botulinum toxin, rehabilitation, and surgical treatments including deep brain stimulation.

This program is supported in part by an educational grant from Merz Pharmaceuticals, LLC and Ipsen Biopharmaceuticals, Inc.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Introductory

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Didactic

Program Materials Program Evaluations

Event Timeline
07:00 AM - 07:10 AM MDT	Introduction	Introduction Ian Bledsoe, MD, Christopher D. Stephen, MBBS, MB ChB, FRCP, SM
07:10 AM - 08:00 AM MDT	Speaker	Dystonia Diagnosis, Phenomenology, and Etiology Christopher D. Stephen, MBBS, MB ChB, FRCP, SM
08:00 AM - 08:50 AM MDT	Speaker	Treatment of Dystonia Ian Bledsoe, MD
08:50 AM - 09:00 AM MDT	Q&A	Questions & Answers Ian Bledsoe, MD, Christopher D. Stephen, MBBS, MB ChB, FRCP, SM

Faculty Disclosures
Ian Bledsoe, MD	Dr. Bledsoe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Putnam Associates. Dr. Bledsoe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Destum Partners. Dr. Bledsoe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie Inc. The institution of Dr. Bledsoe has received research support from Dystonia Medical Research Foundation. The institution of Dr. Bledsoe has received research support from NIH. The institution of Dr. Bledsoe has received research support from Michael J Fox Foundation.
Christopher D. Stephen, MBBS, MB ChB, FRCP, SM	Dr. Stephen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SwanBio Therapeutics. The institution of Dr. Stephen has received research support from Sanofi. Dr. Stephen has received research support from National Institutes of Health.